Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor Clancy

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|September 7, 2016
Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibitionMarte Jonsson, Harald Bull Ragnum, Cathinka Halle Julin, et al.
Genome Biology|December 25, 2010
The Genomic HyperBrowser: inferential genomics at the sequence levelGeir K Sandve, Sveinung Gundersen, Halfdan Rydbeck, et al.
The Journal of Pathology|January 22, 2013
Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profilingMalin Lando, Saskia M Wilting, Kristin Snipstad, et al.
Journal of Translational Medicine|September 11, 2022
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccinationEspen Basmo Ellingsen, Gergana Bounova, Iliana Kerzeli, et al.
BMC Genomics|July 9, 2011
The differential disease regulomeGeir K Sandve, Sveinung Gundersen, Halfdan Rydbeck, et al.
Oncoimmunology|December 21, 2023
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcomaMorten Nielsen, Tine Monberg, Vibeke Sundvold, et al.
Frontiers in Immunology|February 1, 2024
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccinationMurat Gainullin, Lorenzo Federico, Julie Røkke Osen, et al.
Nucleic Acids Research|May 2, 2013
The Genomic HyperBrowser: an analysis web server for genome-scale dataGeir K Sandve, Sveinung Gundersen, Morten Johansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2018
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AMLAndreas T Björklund, Mattias Carlsten, Ebba Sohlberg, et al.
Frontiers in Immunology|July 28, 2023
Robust spike-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort studyLorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|September 7, 2016
Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibitionMarte Jonsson, Harald Bull Ragnum, Cathinka Halle Julin, et al.
Genome Biology|December 25, 2010
The Genomic HyperBrowser: inferential genomics at the sequence levelGeir K Sandve, Sveinung Gundersen, Halfdan Rydbeck, et al.
The Journal of Pathology|January 22, 2013
Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profilingMalin Lando, Saskia M Wilting, Kristin Snipstad, et al.
Journal of Translational Medicine|September 11, 2022
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccinationEspen Basmo Ellingsen, Gergana Bounova, Iliana Kerzeli, et al.
BMC Genomics|July 9, 2011
The differential disease regulomeGeir K Sandve, Sveinung Gundersen, Halfdan Rydbeck, et al.
Oncoimmunology|December 21, 2023
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcomaMorten Nielsen, Tine Monberg, Vibeke Sundvold, et al.
Frontiers in Immunology|February 1, 2024
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccinationMurat Gainullin, Lorenzo Federico, Julie Røkke Osen, et al.
Nucleic Acids Research|May 2, 2013
The Genomic HyperBrowser: an analysis web server for genome-scale dataGeir K Sandve, Sveinung Gundersen, Morten Johansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2018
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AMLAndreas T Björklund, Mattias Carlsten, Ebba Sohlberg, et al.
Frontiers in Immunology|July 28, 2023
Robust spike-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort studyLorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, et al.
Pageof 5